drugset / Trial / NCT05663073

Pharmacokinetics of Irbesartan/Amlodipine FDC and Co-administration of Irbesartan and Amlodipine in Healthy Volunteers

NCT05663073

Phase 1 Completed 46 enrolled Handok Inc.
RandomizedCrossoverOpen-labelOther

Summary

The purpose of this study is to compare pharmacokinetics and safety of Irbesartan and Amlodipine Fixed Dose Combination and coadministration of mono compounds in healthy adult volunteers

Timeline

Start
2022-09-13
Primary completion
2022-12-15
Completion
2023-04-21

Drugs

EvaluationDrugModalityDoseRoute
Subject Amlodipine Other / unclassified
Subject Irbesartan Small molecule

Indications

No indication recorded.